Skip Navigation

Focus on... Anemia Management

Patients routinely failing to achieve and maintain hemoglobin levels of > or equal to 11gm/dL require the interventional skills of an adept clinician. The following areas of investigation should be considered for all patients failing to meet the CMS clinical performance measure goal for anemia management.

1. Inadequate Epogen dosage.

2. Iron deficiency. This is the most common cause of hyporesponse. Iron stores must be sufficient to support new red cell formation.

3. Blood loss.

4. Infection/inflammation. Interferes with red cell production by: (1) releasing cytokines, which inhibit red cell precursors, and (2) impairing iron metabolism.

5. Secondary hyperparathyroidism. Interferes with red cell production by
(1) directly inhibiting of red cell development, and (2) diminishing bone marrow space due to marrow fibrosis

6. Aluminum toxicity. Interferes with red cell production by (1) inhibiting
enzymes necessary for red cell growth, (2) interfering with iron transport, and, (3) increasing fragility of red blood cells.

7. Additional medical conditions

8. Hemolysis. Exacerbates anemia by destroying mature red cells. Causes:

9. Malnutrition. Thought to interfere with red cell production by (1) decreased protein levels lead brain to sense less need for oxygen and decrease hemoglobin production, and (2) decreased proteins available red cell formation.

10. Vitamin deficiency. Water-soluble vitamins are lost during dialysis. Folate and B complex vitamins are necessary for red cell production.

While not all-inclusive, we hope this review will help spotlight potential problem areas and lead to better anemia management outcomes.

If additional clinical assistance is needed, please contact Network 8. We will be glad to assist you with your anemia management efforts.